October « 2015 « Science and Enterprise

Gene Editing Boosts Red Blood Cell Output in Lab

By Alan, on October 23rd, 2015%

Red blood cells illustration (geralt, Pixabay)

23 October 2015. A research team developed a technique with stem cells and gene editing to increase lab production of red blood cells by 3 times, a process that could help people with rare blood types needing transfusions. The researchers led by pediatrics professor Vijay Sankaran at . . . → Read More: Gene Editing Boosts Red Blood Cell Output in Lab

First Results Released from Lung Fibrosis Registry

By Alan, on October 22nd, 2015%

High-resolution CT scan of lungs with idiopathic pulmonary fibrosis (IPF Editor, Wikimedia Commons)

22 October 2015. The first results from a registry of individuals with idiopathic pulmonary fibrosis show most people in the group have limited lung function and show symptoms for about a year before the disease is diagnosed. These findings and . . . → Read More: First Results Released from Lung Fibrosis Registry

Trial Testing Aspirin to Prevent Cancer Recurrence

By Alan, on October 22nd, 2015%

(Mostafa Zeyad, Wikimedia Commons)

22 October 2015. A new late-stage clinical trial is underway in the U.K. testing the ability of a daily aspirin to prevent the recurrence of solid tumor cancers. The trial is financed by the advocacy group Cancer Research UK and National Institute for Health Research, a medical research funding . . . → Read More: Trial Testing Aspirin to Prevent Cancer Recurrence

Gates Grant Funding Whooping Cough Antibody Test

By Alan, on October 21st, 2015%

Jennifer Maynard (University of Texas in Austin)

21 October 2015. A protein engineering lab at University of Texas in Austin is evaluating the potential of an engineered antibody to prevent pertussis, also known as whooping cough, among newborn infants. The study and lab are led by chemical engineering professor Jennifer Maynard, who is . . . → Read More: Gates Grant Funding Whooping Cough Antibody Test

Delivery Technique Devised to Cross Blood-Brain Barrier

By Alan, on October 21st, 2015%

(Allan Ajifo, Wikimedia Commons)

21 October 2015. Medical researchers developed a technique that allows drugs for treating neurological disorders to penetrate the blood-brain barrier, a difficult obstacle up to now. The team led by ear, nose, and throat, or ENT, specialist Benjamin Bleier at Massachusetts Eye and Ear Hospital and Harvard Medical School . . . → Read More: Delivery Technique Devised to Cross Blood-Brain Barrier

Immunotherapy Start-Up Gains $102M in Venture Funds

By Alan, on October 20th, 2015%

(National Cancer Institute)

20 October 2015. A new enterprise founded by researchers in the U.S. and Europe that aims to provide personalized cancer therapies harnessing the immune system raised $102 million in its first round of venture financing. The company Gritstone Oncology — in San Francisco and Cambridge, Massachusetts — says it plans . . . → Read More: Immunotherapy Start-Up Gains $102M in Venture Funds

Evotec, Foundation Partner on Rare Juvenile Disease

By Alan, on October 20th, 2015%

(DARPA.gov)

20 October 2015. The drug discovery company Evotec AG and Beyond Batten Disease Foundation are collaborating on discovery of new drugs to treat juvenile Batten disease, a rare inherited neurodegenerative disorder. Financial details of the partnership were not revealed.

Batten disease is a rare genetic condition of the nervous system that in . . . → Read More: Evotec, Foundation Partner on Rare Juvenile Disease

Novartis Licensing Depression Therapy Technology

By Alan, on October 19th, 2015%

(Lloyd Morgan, Flickr)

19 October 2015. Luc Therapeutics, a biotechnology company designing treatments for psychiatric and neurological disorders, is licensing part of its technology to the pharmaceutical company Novartis to develop treatments for depression. Dollar amounts paid under the agreement to Luc Therapeutics, in Cambridge, Massachusetts, were not disclosed.

Depression is a widespread . . . → Read More: Novartis Licensing Depression Therapy Technology

Help Us Do Science

By Alan, on October 19th, 2015%

(Rusty Clark, Flickr)

Updated 21 November 2015. The survey is now closed. Thank you for taking part.

19 October 2015. We’ve teamed up with researcher Paige Brown Jarreau to create a survey of Science and Enterprise readers. By participating, you’ll be helping me improve Science and Enterprise and contributing to the science of . . . → Read More: Help Us Do Science

On the Road Again

By Alan, on October 15th, 2015%

(LSC, Pixabay)

15 October 2015. Science & Enterprise will be traveling today and Friday, so there will be no posts on either of those days. We will resume our regular posting on Monday, 19 October.

* * *

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise